Idiopathic Pulmonary Fibrosis Treatment
Links shared publicly online about this topic
ATS Issues Idiopathic Pulmonary Fibrosis Treatment Guideline - QualityPoint Technologies
qualitypointtech.net — “The American Thoracic Society has issued new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on March 27, 2011 at 7:35 pm By:
ATS Issues Idiopathic Pulmonary Fibrosis Treatment Guideline: The American Thoracic Society has issued new officia... http://bit.ly/gLMaxi
Idiopathic pulmonary fibrosis : The Lancet
thelancet.com — “Idiopathic pulmonary fibrosis. By - Prof Talmadge E King MD, Prof Annie Pardo PhD, Moisés Selman MD” View full resource at thelancet.com
Most Recently Shared on June 28, 2011 at 3:57 pm By:
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial http://t.co/ZxItNgT
Pulmonary Fibrosis, Idiopathic: eMedicine Pulmonology
emedicine.medscape.com — “Overview: Idiopathic pulmonary fibrosis (IPF) is an idiopathic interstitial pneumonia that is characterized histopathologically by the presence of usual interstitial pneumonia. Of the 7 listed idiopathic interstitial pneumonias in the American Thoracic Society/European Respiratory Society consensus statement ...” View full resource at emedicine.medscape.com
Most Recently Shared on July 23, 2010 at 12:48 pm By:
Pulmonary fibrosis: New population stats and pathophysiology findings, plus the latest on several treatment trials at http://bit.ly/arpyyd
Idiopathic pulmonary fibrosis : The Lancet
thelancet.com — “Idiopathic pulmonary fibrosis. By - Prof Talmadge E King MD, Prof Annie Pardo PhD, Moisés Selman MD” View full resource at thelancet.com
Most Recently Shared on June 28, 2011 at 3:56 pm By:
Read a Seminar on idiopathic pulmonary fibrosis http://t.co/po3jdl7
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis
medicalnewstoday.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published” View full resource at medicalnewstoday.com
Most Recently Shared on March 18, 2011 at 9:05 am By:
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis http://mnt.to/3Sr6 #asthma
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis
medicalnewstoday.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published” View full resource at medicalnewstoday.com
Most Recently Shared on March 19, 2011 at 8:05 am By:
ATS Issues Joint Statement On The Treatment Of Idiopathic Pulmonary Fibrosis http://mnt.to/3Svk #asthma
American Thoracic Society issues statement on the treatment of idiopathic pulmonary fibrosis
sciencedaily.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published in 2000, and reviews current knowledge in the epidemiology, etiology, diagnosis and management of IPF, as well as available treatment options, including pharmacologic and non-pharmacologic therapies and palliative care.” View full resource at sciencedaily.com
Most Recently Shared on March 18, 2011 at 2:13 am By:
American Thoracic Society issues statement on the treatment of idiopathic pulmonary fibrosis: The American Thora... http://bit.ly/eBG2Of
ATS Issues Joint Statement on the Treatment of Idiopathic Pulmonary Fibrosis
newswise.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published in 2000, and reviews current knowledge in the epidemiology, etiology, diagnosis and management of IPF, as well as available treatment options, including pharmacologic and non-pharmacologic therapies and palliative care.” View full resource at newswise.com
Most Recently Shared on March 17, 2011 at 5:35 pm By:
newswise Health Communicator and Health News
ATS Issues Joint Statement on the Treatment of Idiopathic Pulmonary Fibrosis: The American Thoracic Society has ... http://bit.ly/hYOI9a
ATS Issues Joint Statement on the Treatment of Idiopathic Pulmonary Fibrosis
newswise.com — “The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). The statement replaces ATS guidelines published in 2000, and reviews current knowledge in the epidemiology, etiology, diagnosis and management of IPF, as well as available treatment options, including pharmacologic and non-pharmacologic therapies and palliative care.” View full resource at newswise.com
Most Recently Shared on March 17, 2011 at 6:00 pm By:
#health news: ATS Issues Joint Statement on the Treatment of Idiopathic Pulmonary Fibrosis: The American Thoraci... http://bit.ly/fD2Qet
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis - ONA
oncologynurseadvisor.com — “InterMune announced positive data from its CAPACITY Program studying pirfenidone for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 16, 2011 at 3:47 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis http://goo.gl/fb/vWdYN
Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis - MPR
empr.com — “InterMune announced positive data from its CAPACITY Program studying pirfenidone for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).” View full resource at empr.com
Most Recently Shared on May 16, 2011 at 3:32 pm By:
MPR News: Phase 3 Studies of Pirfenidone for Idiopathic Pulmonary Fibrosis: InterMune announced positive data fr... http://bit.ly/jgTAOZ
Survival Of Patients With Idiopathic Pulmonary Fibrosis (IPF) Does Not Improve With Interferon Gamma-1b Treatment
medicalnewstoday.com — “An article published online first and in an upcoming edition of the lancet reports the findings of the inspire trial on treatment of idiopathic pulmonary fibrosis (ipf) with interferon gamm” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2009 at 10:08 am By:
Survival Of Patients With Idiopathic Pulmonary Fibrosis (IPF) Does Not Improve With Interferon Gamma-1b Treatmen.. http://bit.ly/35ImYN
NeoPharm Announces IND Filing For IL13-PE38QQR For The Treatment Of Idiopathic Pulmonary Fibrosis
medicalnewstoday.com — “Neopharm, inc. (other otc: neol.pk), announced today that it has filed an investigational new drug application (ind) with the u.s. food and drug administration (fda) for il13-pe38qqr (il13-pe) for” View full resource at medicalnewstoday.com
Most Recently Shared on January 6, 2010 at 4:06 am By:
NeoPharm Announces IND Filing For IL13-PE38QQR For The Treatment Of Idiopathic Pulmonary Fibrosis http://mnt.to/3vX2
Orphan drug designation granted to IL13-PE for the treatment of idiopathic pulmonary fibrosis (IPF) - ONA
oncologynurseadvisor.com — “NeoPharm was granted orphan drug designation by the FDA for its drug candidate, IL 13-PE (also known as IL13-PE38QQR) for the treatment of idiopathic pulmonary fibrosis (IPF).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 17, 2010 at 7:55 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Orphan drug designation granted to IL13-PE for the treatment of idiopathic pulmonary fibrosis… http://goo.gl/fb/aWTBd
Orphan drug designation granted to IL13-PE for the treatment of idiopathic pulmonary fibrosis (IPF) - MPR
empr.com — “NeoPharm was granted orphan drug designation by the FDA for its drug candidate, IL 13-PE (also known as IL13-PE38QQR) for the treatment of idiopathic pulmonary fibrosis (IPF).” View full resource at empr.com
Most Recently Shared on May 17, 2010 at 10:47 pm By:
MPR News: Orphan drug designation granted to IL13-PE for the treatment of idiopathic pulmonary fibrosis (IPF): Neo... http://bit.ly/b2fNHA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
Medscape
Health and medical news and alerts, CME, medical conference coverage and drug information for physicians and other health professionals.
Advertisement
